“…Mice of the second group (6 WT and 6 mdx animals), referred to as relaxin-pretreated WT or mdx mice, received a single subcutaneous injection of 2 g of highly purified porcine relaxin (2,500 -3,000 U/mg) prepared according to the method of Sherwood and O'Byrne (57) and generously donated by Dr. O. D. Sherwood, University of Illinois (Urbana, IL). The hormone was dissolved in 0.2 ml of 1% benzopurpurin (Fluka, Buchs, Switzerland) in PBS, a repository vehicle that allows a slow release of the hormone over 24 h. The chosen dose, vehicle, and route of administration were in the range of those previously used in mice and proved effective to upregulate NOS expression (3,5,6,9,10). The mice of the third group (6 WT and 6 mdx animals) received the vehicle alone and are referred to as vehicle-pretreated WT or mdx mice.…”